Treating depression during COVID-19: Considerations for psychological and psychiatric treatment
This is the first in a series of two live, interactive webinar presentations (90 minutes each) which will focus on how best to deliver treatment of depression during the COVID-19 pandemic. Designed for intermediate and advanced practitioners already familiar with cognitive-behavioral and pharmacological interventions for depression, this presentation will review behavioral activation theory and implementation, pharmacotherapy for depression, and the benefits of a combined approach. Pharmacological and therapeutic considerations, as well as necessary modifications in light of the COVID-19 pande...Read moremic, will be discussed, including the implementation of treatment via telehealth. Ample time will be allotted at the end of the presentation to address audience questions. Less...
Learning Objectives
- Present the rationale for behavioral activation along with at least two specific examples for each aspect of the TRAP model.
- Identify at least two modifications to pharmacotherapy due to the COVID-19 pandemic, including use of telepsychiatry.
- Identify at least two adaptations to the implementation of behavioral activation in light of COVID-19 and/or use of telehealth.
Learning Levels
- Intermediate to Advanced
Thursday, April 30, 2020
01:00 PM EDT - 02:30 PM EDT
About the speakers
CE Information - Earn 1.5 CE Credit Hours
CE Approvals
American Psychological Association
Association of Social Work Boards
National Board for Certified Counselors
Other Professionals
CE Process Info
A Contuing Education Certificate for this program will be obtained usingthe website CE Go. After the event, you will receive an email with a link to CE Go. This link will be emailed to the account you used to register for this event.
Upon accessing the CE-Go website, you will be able to:
- Complete the mandatory evaluation form
- Download your CE Certificate in PDF form
Please Note: To receive CE credit, you must be logged into the webinar for the entire program; partial credit is not available.
AGENDA
1 pm EDT Welcome and speaker introductions
1:05 pm Behavioral activation for the treatment of depression
• Theoretical background and treatment rationale
• Activity scheduling
• Rumination
Pharmacotherapy
• Standard practices for treating depression
Benefits of a combined approach
• Efficacy of behavioral activation with medication
Considerations in light of COVID-19
• Telehealth recommendations
• Modifications to psychiatry
• Modifications to therapy
2:15 pm Moderated Q&A
2:30 pm Where to get additional information on this topic